Application 202471
- Type
- ANDA
- Sponsor
- MYLAN INSTITUTIONAL
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | BIVALIRUDIN | BIVALIRUDIN | INJECTABLE;INTRAVENOUS | 250MG/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 67457-256 | Bivalirudin | bivalirudin | Mylan Institutional LLC | ANDA | Current |
| 67457-256 | Bivalirudin | bivalirudin | Mylan Institutional LLC | ANDA | Current |
| 67457-256 | Bivalirudin | bivalirudin | Mylan Institutional LLC | ANDA | Current |
| 67457-256 | Bivalirudin | bivalirudin | Mylan Institutional LLC | ANDA | Current |